Shurong Hu

Shurong Hu

Auto-generated profile, based on publicly available information

Shurong Hu

Center for Inflammatory Bowel Diseases, Department of Gastroenterology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
乔余乔 余
乔 余
CZChunpeng Zhu
Chunpeng Zhu
SFShuyi Feng
Shuyi Feng
LXLiyi Xu
Liyi Xu
SHShurong Hu
Shurong Hu
YCYan Chen
Yan Chen
Background: The increasing incidence of inflammatory bowel disease (IBD) has imposed heavy financial burdens for Chinese patients; however, data about their financial status and access to health care are still lacking. This information is important for informing patients with IBD about disease treatment budgets and health care strategies. Objective: The aim of this study was to evaluate the economic status and medical care access of patients with IBD through the China Crohn’s & Colitis Foundation web-based platform in China. Methods: Our study was performed in 14 IBD centers in mainland China between 2018 and 2019 through WeChat. Participants were asked to complete a 64-item web-based questionnaire. Data were collected by the Wenjuanxing survey program. We mainly focused on income and insurance status, medical costs, and access to health care providers. Respondents were stratified by income and the associations of income with medical costs and emergency visit times were analyzed. Results: In this study, 3000 patients with IBD, that is, 1922 patients with Crohn disease, 973 patients with ulcerative colitis, and 105 patients with undetermined colitis were included. During the last 12 months, the mean (SD) direct and indirect costs for per patient with IBD were approximately US $11,668.68 ($7944.44) and US $74.90 ($253.60) in China. The average reimbursement ratios for most outpatient and inpatient costs were less than 50%. However, the income of 85.5% (2565/3000) of the patients was less than ¥10,000 (US $1445) per month. Approximately 96.5% (2894/3000) of the patients were covered by health insurance, but only 24.7% (741/3000) of the patients had private commercial insurance, which has higher imbursement ratios. Nearly 98.0% (2954/3000) of the patients worried about their financial situation. Thus, 79.7% (2392/3000) of the patients with IBD tried to save money for health care and even delayed their medical treatments. About half of the respondents (1282/3000, 42.7%) had no primary care provider, and 52.2% (1567/3000) of the patients had to visit the emergency room 1-4 times per year for the treatment of their IBD. Multivariate analysis revealed that lower income (P=.001) and higher transportation (P=.004) and accommodation costs (P=.001) were significantly associated with the increased number of emergency visits of the patients. Conclusions: Chinese patients with IBD have enormous financial burdens and difficulties in accessing health care, which have increased their financial anxiety and inevitably influenced their disease outcomes. Early purchase of private insurance, thereby increasing the reimbursement ratio for medical expenses, and developing the use of telemedicine would be effective strategies for saving on health care costs.

14 August 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
SLShuyan Li
Shuyan Li
YMYan Ma
Yan Ma
HSHongling Sun
Hongling Sun
ZNZijun Ni
Zijun Ni
SHShurong Hu
Shurong Hu
MLMeijuan Lan
Meijuan Lan
Objective: Crohn’s disease (CD) is an incurable chronic disease that requires long-term treatment. As an anti-tumor necrosis factor (TNF) agent, Infliximab (IFX) is widely used in the treatment of Crohn’s disease, while the adherence is not high. The purpose of this study was to investigate the adherence to IFX among CD patients in China and evaluate the association between medication belief and IFX adherence.Methods: Demographic data, clinical information and patients’ medication beliefs were collected using an online questionnaire and reviewing electronic medical records (EMRs). The Beliefs about Medicines Questionnaire (BMQ)-specific was used to assess medication beliefs which contains the BMQ-specific concern score and the BMQ-specific necessity score. An evaluation of adherence factors was conducted using univariate and multidimensional logistic regression analyses.Results: In all, 166 CD patients responded the online questionnaire among which 77 (46.39%) patients had high adherence. The BMQ-specific concern score in patients in low adherence was 30.00 and in high adherence patients was 27.50, and patients with lower BMQ-specific concern score had higher adherence (p = 0.013). The multiple regression analysis showed that the BMQ-specific concern score (OR = 0.940, 95% CI: 0.888–0.996) significantly affected the IFX adherence in CD patients. Otherwise, gender, marital status, time spent on the way (including the waiting time in infusion center) and accommodation to the center were also the influencing factors of adherence.Conclusion: The IFX adherence to CD in China was not high. Medicine concerns may be predictive factor of adherence. Education, the duration of IFX therapy and experience of adverse effects were not significantly associated with IFX adherence. By enhancing knowledge and relieving medicine concerns, we may increase patients’ adherence to IFX.

29 June 2022 in JMIR Preprints
Verified
Preprint
Open access
SXSong Xu
Song Xu
乔余乔 余
乔 余
SLShuyan Li
Shuyan Li
SHShurong Hu
Shurong Hu
WHWen Hu
Wen Hu
YCYan Chen
Yan Chen
BACKGROUND Inflammatory bowel diseases (IBD) cause work impairments for working-age patients. Limited data are available concerning impacts of disease burden on quality of working life for patients with IBD in China. This information is important for reducing indirect costs of IBD which are mainly driven by work productivity (WP) loss. OBJECTIVE This study aimed to evaluate the situation of working life of patients with IBD in China and identify impairing factors predictive for work satisfaction decline and WP loss. METHODS This was a web-based cross-sectional cohort study performed through the WeChat public platform of China Crohn’s & Colitis Foundation. Patients with IBD completed an 82-item online questionnaire consisted of five sections, including [ⅰ] sociodemographic survey; [ⅱ] disease-related survey including the patient-reported Harvey Bradshaw Index (p-HBI) and the patient-reported Simple Clinical Colitis Activity Index (p-SCCAI) questionnaire to assess disease activity; [ⅲ] work-related survey; [ⅳ] the Work Productivity and Activity Impairment (WPAI) questionnaire to assess absenteeism, presenteeism and overall WP loss; and [ⅴ] a 22-item IBD quality-of-life questionnaire (IBDQOL-22) to assess health-related quality of life (HRQOL). Uni- and multivariable regression analyses were performed to identify predictors of work satisfaction decline and WP loss. RESULTS A total of 1610 IBD patients were included (67% Crohn’s disease, 71% actively employed). 468 (41%) of 1141 actively employed patients reported IBD-related limitation in working ability and 357 (76%) of 469 previously employed patients stopped work because of IBD. Fatigue and biological therapy were reported to impact working life most. In 1141 actively employed patients, work satisfaction decline, absenteeism, presenteeism, and overall WP loss were reported by 474 (42%), 423 (37%), 947 (83%), and 965 (85%) patients, respectively. Multivariate analysis revealed that aging over 30 years old (P < .001), working over 40 hours per week (P = .009), anxiety/depression (P < .001) and disease activity (P = .002) were predictive for work satisfaction decline. Low education level (P < .001), anxiety/depression (P < .001), irritability mood (P = .009) and high disease burden presented by relapse frequency ≥ 3 flare-ups per year (P = .026), hospitalizations > 3 times per year (P = .013) and disease activity (P < .001) were predictive for severe WP loss. Moreover, poor HRQOL was associated with WP loss. CONCLUSIONS High disease burden significantly impairs quality of working life in Chinese IBD patients. Age, education, working hours and mental health synergistically correlate with work satisfaction decline or WP loss.

24 May 2020 in JMIR Preprints
Verified
Preprint
Open access
乔余乔 余
乔 余
CZChunpeng Zhu
Chunpeng Zhu
SFShuyi Feng
Shuyi Feng
LXLiyi Xu
Liyi Xu
SHShurong Hu
Shurong Hu
YCYan Chen
Yan Chen
BACKGROUND The increasing incidence of inflammatory bowel disease (IBD) has imposed heavy financial burdens for Chinese patients; however, data about their financial status and access to health care are still lacking. This information is important for informing patients with IBD about disease treatment budgets and health care strategies. OBJECTIVE The aim of this study was to evaluate the economic status and medical care access of patients with IBD through the China Crohn’s & Colitis Foundation web-based platform in China. METHODS Our study was performed in 14 IBD centers in mainland China between 2018 and 2019 through WeChat. Participants were asked to complete a 64-item web-based questionnaire. Data were collected by the Wenjuanxing survey program. We mainly focused on income and insurance status, medical costs, and access to health care providers. Respondents were stratified by income and the associations of income with medical costs and emergency visit times were analyzed. RESULTS In this study, 3000 patients with IBD, that is, 1922 patients with Crohn disease, 973 patients with ulcerative colitis, and 105 patients with undetermined colitis were included. During the last 12 months, the mean (SD) direct and indirect costs for per patient with IBD were approximately US $11,668.68 ($7944.44) and US $74.90 ($253.60) in China. The average reimbursement ratios for most outpatient and inpatient costs were less than 50%. However, the income of 85.5% (2565/3000) of the patients was less than ¥10,000 (US $1445) per month. Approximately 96.5% (2894/3000) of the patients were covered by health insurance, but only 24.7% (741/3000) of the patients had private commercial insurance, which has higher imbursement ratios. Nearly 98.0% (2954/3000) of the patients worried about their financial situation. Thus, 79.7% (2392/3000) of the patients with IBD tried to save money for health care and even delayed their medical treatments. About half of the respondents (1282/3000, 42.7%) had no primary care provider, and 52.2% (1567/3000) of the patients had to visit the emergency room 1-4 times per year for the treatment of their IBD. Multivariate analysis revealed that lower income (P=.001) and higher transportation (P=.004) and accommodation costs (P=.001) were significantly associated with the increased number of emergency visits of the patients. CONCLUSIONS Chinese patients with IBD have enormous financial burdens and difficulties in accessing health care, which have increased their financial anxiety and inevitably influenced their disease outcomes. Early purchase of private insurance, thereby increasing the reimbursement ratio for medical expenses, and developing the use of telemedicine would be effective strategies for saving on health care costs.